First Header Logo Second Header Logo

Sheila Conway

Concepts (171)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma
10
2021
73
2.400
Why?
Bone Neoplasms
12
2020
111
2.380
Why?
Soft Tissue Neoplasms
8
2021
39
2.130
Why?
Brachytherapy
2
2018
24
1.010
Why?
Orthopedics
2
2019
90
0.730
Why?
Spine
1
2019
41
0.660
Why?
Spinal Neoplasms
1
2019
22
0.660
Why?
Incidental Findings
1
2019
25
0.650
Why?
Joint Instability
2
2019
76
0.650
Why?
Diffusion of Innovation
1
2018
34
0.620
Why?
Interdisciplinary Communication
1
2018
58
0.610
Why?
Internship and Residency
2
2019
313
0.600
Why?
Radiation Dosage
1
2018
84
0.600
Why?
Humerus
2
2013
32
0.590
Why?
Chondrosarcoma
4
2020
7
0.570
Why?
Decision Support Techniques
1
2018
128
0.560
Why?
Neoplasm Recurrence, Local
7
2021
367
0.550
Why?
Lipoma
1
2015
7
0.510
Why?
Tendon Injuries
1
2014
38
0.470
Why?
Humans
31
2021
32114
0.440
Why?
Osteochondroma
1
2013
2
0.440
Why?
Giant Cell Tumors
1
2013
4
0.440
Why?
Limb Salvage
7
2021
22
0.440
Why?
Tendons
1
2013
59
0.420
Why?
Wrist Joint
1
2013
60
0.420
Why?
Magnetic Resonance Imaging
11
2020
1328
0.420
Why?
Cell Proliferation
2
2020
604
0.400
Why?
Antimicrobial Cationic Peptides
2
2020
14
0.360
Why?
Retrospective Studies
12
2021
3510
0.360
Why?
Middle Aged
17
2020
11839
0.350
Why?
Radiography
4
2016
376
0.350
Why?
Neoplastic Stem Cells
2
2020
99
0.340
Why?
Adult
15
2020
9380
0.320
Why?
Femoral Neoplasms
2
2010
4
0.270
Why?
Female
18
2020
20015
0.260
Why?
Male
15
2018
19217
0.260
Why?
Aged
13
2018
10314
0.260
Why?
Neoplasm, Residual
4
2016
25
0.260
Why?
Predictive Value of Tests
3
2018
876
0.250
Why?
Physical Examination
3
2013
92
0.250
Why?
Fibrous Dysplasia of Bone
2
2014
2
0.240
Why?
Treatment Outcome
7
2018
3306
0.240
Why?
Biopsy
3
2013
259
0.240
Why?
Young Adult
8
2020
2665
0.220
Why?
Biopsy, Needle
2
2016
93
0.210
Why?
Radiotherapy, Adjuvant
3
2018
78
0.210
Why?
Fractures, Spontaneous
2
2019
16
0.210
Why?
Aged, 80 and over
8
2016
3990
0.210
Why?
Adolescent
8
2016
3568
0.200
Why?
Amyloidosis
1
2021
14
0.200
Why?
Orthopedic Procedures
2
2019
89
0.190
Why?
Joint Diseases
1
2021
37
0.190
Why?
Tibia
2
2014
56
0.190
Why?
Giant Cell Tumor of Bone
1
2010
5
0.180
Why?
Proto-Oncogene Proteins B-raf
1
2020
8
0.180
Why?
Bone Transplantation
2
2016
45
0.170
Why?
Office Visits
1
2010
73
0.170
Why?
Subcutaneous Fat
1
2020
47
0.170
Why?
Mycetoma
1
2009
1
0.170
Why?
Leg Dermatoses
1
2009
2
0.170
Why?
Ambulatory Care
1
2010
108
0.170
Why?
Foot Diseases
1
2009
10
0.170
Why?
Ulcer
1
2009
3
0.170
Why?
Lymphoma, Large B-Cell, Diffuse
1
2009
15
0.160
Why?
Lower Extremity
1
2020
100
0.160
Why?
Knee Injuries
1
2019
42
0.160
Why?
Palliative Care
1
2019
52
0.160
Why?
Neurosurgical Procedures
1
2019
99
0.160
Why?
Combined Modality Therapy
3
2016
560
0.160
Why?
Patient Care Team
1
2019
129
0.150
Why?
Specialties, Surgical
1
2018
28
0.150
Why?
Surgical Wound Dehiscence
1
2018
13
0.150
Why?
Athletic Injuries
1
2019
83
0.150
Why?
Carcinoma, Squamous Cell
1
2009
154
0.150
Why?
Arthroplasty, Replacement, Knee
1
2019
89
0.150
Why?
Surgical Wound Infection
1
2018
84
0.140
Why?
Range of Motion, Articular
2
2013
187
0.140
Why?
Tarsal Bones
1
2016
5
0.140
Why?
Wound Healing
1
2018
185
0.140
Why?
Nerve Sheath Neoplasms
1
2016
8
0.140
Why?
Pediatrics
1
2018
155
0.140
Why?
Pain
1
2009
288
0.140
Why?
Arthrodesis
1
2016
20
0.140
Why?
Shoulder Joint
1
2008
126
0.140
Why?
Prognosis
5
2015
1497
0.130
Why?
Diagnosis, Differential
4
2014
517
0.130
Why?
Postoperative Complications
2
2020
780
0.130
Why?
Risk Assessment
2
2018
1429
0.120
Why?
Time Factors
2
2018
2151
0.120
Why?
Granuloma, Foreign-Body
1
2014
7
0.120
Why?
Osteitis Deformans
1
2014
2
0.120
Why?
Enchondromatosis
1
2014
3
0.120
Why?
Exostoses, Multiple Hereditary
1
2014
2
0.120
Why?
Sutures
1
2014
20
0.120
Why?
Risk Factors
2
2018
3880
0.110
Why?
Extremities
3
2021
50
0.110
Why?
United States
2
2019
3976
0.110
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2016
458
0.110
Why?
Wound Infection
1
2012
10
0.100
Why?
Radiotherapy, Intensity-Modulated
1
2012
34
0.100
Why?
Recovery of Function
1
2013
199
0.100
Why?
Child
4
2010
2442
0.090
Why?
Cell Survival
2
2020
285
0.080
Why?
Neoplasm Staging
3
2016
447
0.080
Why?
Artificial Limbs
1
2008
1
0.080
Why?
Arthroplasty, Replacement, Hip
1
2008
50
0.080
Why?
Cell Line, Tumor
2
2020
726
0.080
Why?
Reoperation
2
2013
226
0.060
Why?
Follow-Up Studies
3
2016
2265
0.060
Why?
Chemotherapy, Adjuvant
2
2016
190
0.060
Why?
Femur
2
2014
74
0.060
Why?
Disease-Free Survival
2
2016
317
0.050
Why?
beta 2-Microglobulin
1
2021
6
0.050
Why?
Amyloid
1
2021
15
0.050
Why?
Curettage
1
2010
9
0.050
Why?
Antigens, Surface
1
2020
24
0.050
Why?
STAT3 Transcription Factor
1
2020
25
0.050
Why?
Retinal Dehydrogenase
1
2020
2
0.050
Why?
Florida
1
2010
37
0.050
Why?
Spheroids, Cellular
1
2020
37
0.050
Why?
Necrosis
1
2010
53
0.050
Why?
Chromatin
1
2020
25
0.040
Why?
Itraconazole
1
2009
6
0.040
Why?
Toes
1
2009
15
0.040
Why?
Periosteum
1
2009
9
0.040
Why?
Epigenesis, Genetic
1
2020
104
0.040
Why?
Osteosarcoma
1
2009
11
0.040
Why?
Tomography, X-Ray Computed
2
2014
919
0.040
Why?
Hemangioma
1
2009
19
0.040
Why?
Arthrography
1
2009
11
0.040
Why?
Antifungal Agents
1
2009
40
0.040
Why?
Renal Dialysis
1
2021
282
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2020
261
0.040
Why?
Dose-Response Relationship, Drug
1
2020
633
0.040
Why?
Fluoroscopy
1
2008
40
0.040
Why?
Education, Medical, Graduate
1
2019
127
0.040
Why?
Prosthesis Failure
1
2008
45
0.040
Why?
Transplantation, Homologous
1
2008
151
0.040
Why?
Prostheses and Implants
1
2008
42
0.040
Why?
Reproducibility of Results
1
2010
765
0.040
Why?
Knee Joint
1
2009
142
0.040
Why?
Survival Analysis
1
2008
483
0.040
Why?
Pain Measurement
1
2009
350
0.040
Why?
Fracture Fixation, Internal
1
2008
116
0.040
Why?
Comorbidity
1
2009
566
0.040
Why?
Ifosfamide
1
2016
6
0.040
Why?
Multivariate Analysis
1
2008
684
0.030
Why?
Radiotherapy Dosage
1
2016
101
0.030
Why?
Rare Diseases
1
2016
21
0.030
Why?
Cisplatin
1
2016
76
0.030
Why?
Clinical Competence
1
2019
333
0.030
Why?
Proportional Hazards Models
1
2008
753
0.030
Why?
Neoadjuvant Therapy
1
2016
67
0.030
Why?
Doxorubicin
1
2016
82
0.030
Why?
Pregnancy
1
2009
997
0.030
Why?
Positron-Emission Tomography
1
2016
163
0.030
Why?
Skin Transplantation
1
2015
49
0.030
Why?
Ilium
1
2014
15
0.030
Why?
Immunohistochemistry
1
2016
538
0.030
Why?
Surgical Flaps
1
2015
72
0.030
Why?
Pelvic Bones
1
2014
32
0.030
Why?
Survival Rate
1
2016
877
0.030
Why?
Ribs
1
2014
44
0.030
Why?
Calcinosis
1
2014
146
0.030
Why?
Tumor Burden
1
2013
58
0.030
Why?
Lung Neoplasms
1
2013
414
0.020
Why?
Hip Prosthesis
1
2008
14
0.020
Why?
Prosthesis Implantation
1
2008
40
0.020
Why?
Neoplasm Metastasis
1
2008
220
0.020
Why?
Walking
1
2008
209
0.020
Why?
Age Factors
1
2008
1189
0.020
Why?
Conway's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (171)
Explore
_
Co-Authors (1)
Explore
_
Same Department Expand Description
Explore
_